TITLE

Intensive blood glucose control for type 2 diabetes: meta-analysis

PUB. DATE
March 2012
SOURCE
Africa Health;Mar2012, Vol. 34 Issue 3, p59
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on a meta-analysis of intensive blood glucose control for type 2 diabetes, which found that intensive control could not minimize all-cause mortality, however, can increase the risk of severe hypoglycaemia by about 30%.
ACCESSION #
74109806

 

Related Articles

  • Hypoglycaemia exacts extra costs in Canada.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p7 

    The article discusses research on the association of hypoglycemia with medication, discontinuation and costs in type 2 diabetes mellitus patients in Canada, referencing a study by M. Bron and colleagues presented at the 70th Annual Scientific Sessions of the American Diabetes Association.

  • Exenatide more effective than insulinglargine in patients with type 2 diabetes.  // Australian Journal of Pharmacy;Feb2011, Vol. 92 Issue 1089, p71 

    The article presents a case study on the efficacy of exenatide on patients with type 2 diabetes. In the study, exenatide was compared with insulin gargine in adults with type 2 diabetes who had subtimum glycaemic control despite use of maximum tolerated doses of blood-glucose-lowering drugs for...

  • Antibacterials/insulin detemir/omeprazole interaction.  // Reactions Weekly;8/1/2013, Issue 1463, p9 

    The article presents a case study of an 82-year-old man with hypoglycaemia, which developed during treatment with amoxicillin, clarithromycin, omeprazole and insulin detemir for type 2 diabetes.

  • PEDIATRIC MANAGEMENT PROBLEMS. Belkengren, Richard; Sapala, Shirley // Pediatric Nursing;Mar/Apr2000, Vol. 26 Issue 2, p182 

    Presents the case of a 14-year-old female with Type I diabetes. Social and family history; Factors that contributed to the occurrence of hypoglycemia; Treatment for the disease.

  • Pharmacologic management of type 2 diabetes in the elderly: Overview of treatment... da Silva, Barbara A. // Formulary;Jul2000, Vol. 35 Issue 7, p580 

    Evaluates treatment options for type 2 diabetes in the elderly. Complications requiring special consideration in the elderly; Glycemic control techniques; Oral hypoglycemic medications; Combination therapy; Adverse effects; Drug interactions; Dosage administration.

  • Treatment of type II diabetes. Nattrass, Malcolm // British Medical Journal (Clinical Research Edition);4/19/1986, Vol. 292 Issue 6527, p1033 

    Focuses on the clinical management of type II diabetes. Mechanism of action of sulphonylureas; Shift from long to a short acting drug among older patients; Control of hypoglycemia by administering oral hypoglycemic agents.

  • Adjunctive prandial or biphasic insulin for type 2 diabetes improved glycaemic control but increased hypoglycaemia and weight gain. Hollmand, R. R. // Evidence Based Medicine;Jun2008, Vol. 13 Issue 3, p77 

    STUDY DESIGN Design: randomised controlled trial (Treating to Target in Type 2 Diabetes [4-T]). Allocation: concealed. Blinding: unblinded. STUDY QUESTION Setting: 58 centres in Ireland and the UK. Patients: 708 patients ⩾18 years of age (mean age 62 y, 64% men) who had type 2 diabetes for...

  • Clinical pharmacokinetics: brief reports.  // Drugs & Therapy Perspectives;Apr2006, Vol. 22 Issue 4, p16 

    Advances in treatment for type 2 diabetes mellitus have seen an increase in polypharmacy. A higher incidence of hypoglycaemia may occur when multiple antihyperglycaemic agents are used. Potential interactions between oral glucose-lowering agents and other drugs (e.g. those that are widely...

  • Effects of drug-drug interactions involving oral antihyperglycaemics are, with the exception of hypoglycaemia, mostly clinically unimportant.  // Drugs & Therapy Perspectives;Apr2006, Vol. 22 Issue 4, p18 

    Advances in treatment for type 2 diabetes mellitus have seen an increase in polypharmacy. A higher incidence of hypoglycaemia may occur when multiple antihyperglycaemic agents are used. Potential interactions between oral glucose-lowering agents and other drugs (e.g. those that are widely...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics